{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:41:47Z","timestamp":1787856107204,"version":"build-2784847793"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T00:00:00Z","timestamp":1423008000000},"content-version":"vor","delay-in-days":368,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structure"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.str.2013.11.009","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T19:03:36Z","timestamp":1388775816000},"page":"291-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Structural Basis of Prion Inhibition by Phenothiazine Compounds"],"prefix":"10.1016","volume":"22","author":[{"given":"Pravas\u00a0Kumar","family":"Baral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mridula","family":"Swayampakula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj\u00a0Kumar","family":"Rout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00a0N.V.","family":"Kav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Spyracopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Aguzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael\u00a0N.G.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.str.2013.11.009_bib1","doi-asserted-by":"crossref","first-page":"e1000113","DOI":"10.1371\/journal.ppat.1000113","article-title":"Prion protein amino acid determinants of differential susceptibility and molecular feature of prion strains in mice and voles","volume":"4","author":"Agrimi","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.str.2013.11.009_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0092-8674(03)01031-6","article-title":"Mammalian prion biology: one century of evolving concepts","volume":"116","author":"Aguzzi","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.str.2013.11.009_bib3","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1073\/pnas.0809170106","article-title":"Crystal structure of human prion protein bound to a therapeutic antibody","volume":"106","author":"Antonyuk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2013.11.009_bib4","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1074\/jbc.M313581200","article-title":"The effect of disease-associated mutations on the folding pathway of human prion protein","volume":"279","author":"Apetri","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.str.2013.11.009_bib5","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1107\/S0907444912037328","article-title":"Structural studies on the folded domain of the human prion protein bound to the Fab fragment of the antibody POM1","volume":"68","author":"Baral","year":"2012","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2013.11.009_bib6","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1128\/JVI.79.12.7785-7791.2005","article-title":"Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets","volume":"79","author":"Bertsch","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.str.2013.11.009_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.str.2013.11.009_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.str.2013.11.009_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cell.2005.02.011","article-title":"In\u00a0vitro generation of infectious scrapie prions","volume":"121","author":"Castilla","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.str.2013.11.009_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.biochem.78.082907.145410","article-title":"Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions","volume":"78","author":"Caughey","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.str.2013.11.009_bib11","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/ct301118j","article-title":"Decrypting Prion Protein Conversion into a \u03b2-Rich Conformer by Molecular Dynamics","volume":"9","author":"Chakroun","year":"2013","journal-title":"J.\u00a0Chem. Theory Comput."},{"key":"10.1016\/j.str.2013.11.009_bib12","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1073\/pnas.1306178110","article-title":"Structural plasticity of the cellular prion protein and implications in health and disease","volume":"110","author":"Christen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2013.11.009_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","article-title":"Prion diseases of humans and animals: their causes and molecular basis","volume":"24","author":"Collinge","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.str.2013.11.009_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/383685a0","article-title":"Molecular analysis of prion strain variation and the aetiology of \u2018new variant\u2019 CJD","volume":"383","author":"Collinge","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.str.2013.11.009_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1474-4422(09)70049-3","article-title":"Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial","volume":"8","author":"Collinge","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.str.2013.11.009_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.biocel.2010.11.007","article-title":"High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion protein","volume":"43","author":"Corsaro","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.str.2013.11.009_bib17","doi-asserted-by":"crossref","first-page":"13794","DOI":"10.1128\/JVI.01502-07","article-title":"Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures","volume":"81","author":"Cronier","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.str.2013.11.009_bib18","doi-asserted-by":"crossref","first-page":"17308","DOI":"10.1073\/pnas.1106325108","article-title":"Cellular prion protein conformation and function","volume":"108","author":"Damberger","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2013.11.009_bib19","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N.Log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.str.2013.11.009_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00197809","article-title":"NMRPipe: a multidimensional spectral processing system based on UNIX pipes","volume":"6","author":"Delaglio","year":"1995","journal-title":"J.\u00a0Biomol. NMR"},{"key":"10.1016\/j.str.2013.11.009_bib21","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/JVI.74.10.4894-4897.2000","article-title":"Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation","volume":"74","author":"Doh-Ura","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.str.2013.11.009_bib22","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2013.11.009_bib23","doi-asserted-by":"crossref","first-page":"36487","DOI":"10.1074\/jbc.C000579200","article-title":"In\u00a0vivo cytotoxicity of the prion protein fragment 106-126","volume":"275","author":"Ettaiche","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.str.2013.11.009_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/362543a0","article-title":"Neurotoxicity of a prion protein fragment","volume":"362","author":"Forloni","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.str.2013.11.009_bib25","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.0b013e3182a9f3b4","article-title":"Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease","volume":"81","author":"Geschwind","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.str.2013.11.009_bib26","doi-asserted-by":"crossref","first-page":"e1000673","DOI":"10.1371\/journal.ppat.1000673","article-title":"Continuous quinacrine treatment results in the formation of drug-resistant prions","volume":"5","author":"Ghaemmaghami","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.str.2013.11.009_bib27","series-title":"The Pharmacological Basis of\u00a0Therapeutics; a Textbook of Pharmacology, Toxicology, and Therapeutics for Physician and Medical Students","author":"Goodman","year":"1970"},{"key":"10.1016\/j.str.2013.11.009_bib28","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1074\/jbc.M110.213926","article-title":"Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion","volume":"286","author":"Hafner-Bratkovic","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.str.2013.11.009_bib29","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awm063","article-title":"Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance","volume":"130","author":"Heinemann","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.str.2013.11.009_bib30","doi-asserted-by":"crossref","first-page":"28515","DOI":"10.1074\/jbc.M313762200","article-title":"The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC","volume":"279","author":"Hosszu","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.str.2013.11.009_bib31","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1046\/j.1471-4159.1999.0731557.x","article-title":"The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126","volume":"73","author":"Jobling","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.str.2013.11.009_bib32","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/pro.231","article-title":"Differential stability of the bovine prion protein upon urea unfolding","volume":"18","author":"Julien","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.str.2013.11.009_bib33","series-title":"Computer Aided Resonance Assignment Tutorial","author":"Keller","year":"2004"},{"key":"10.1016\/j.str.2013.11.009_bib34","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1128\/JVI.77.19.10288-10294.2003","article-title":"New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products","volume":"77","author":"Kocisko","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.str.2013.11.009_bib35","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"Korth","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2013.11.009_bib36","doi-asserted-by":"crossref","first-page":"11921","DOI":"10.1073\/pnas.0702671104","article-title":"Hot spots in prion protein for pathogenic conversion","volume":"104","author":"Kuwata","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2013.11.009_bib37","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jmb.2008.03.035","article-title":"Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein","volume":"378","author":"Lee","year":"2008","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.str.2013.11.009_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/emboj.2009.333","article-title":"Conformational diversity in prion protein variants influences intermolecular beta-sheet formation","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.str.2013.11.009_bib39","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1099\/vir.0.81630-0","article-title":"Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation","volume":"87","author":"Lewis","year":"2006","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.str.2013.11.009_bib40","doi-asserted-by":"crossref","first-page":"046101","DOI":"10.1063\/1.2431176","article-title":"A common, avoidable source of error in molecular dynamics integrators","volume":"126","author":"Lippert","year":"2007","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.str.2013.11.009_bib41","doi-asserted-by":"crossref","first-page":"e19093","DOI":"10.1371\/journal.pone.0019093","article-title":"Dynamic diagnosis of familial prion diseases supports the \u03b22-\u03b12 loop as a universal interference target","volume":"6","author":"Meli","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.str.2013.11.009_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2013.11.009_bib43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000076350","article-title":"Results of quinacrine administration to patients with Creutzfeldt-Jakob disease","volume":"17","author":"Nakajima","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.str.2013.11.009_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of x-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.str.2013.11.009_bib45","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm883","article-title":"A prion protein epitope selective for the pathologically misfolded conformation","volume":"9","author":"Paramithiotis","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.str.2013.11.009_bib46","doi-asserted-by":"crossref","first-page":"e3872","DOI":"10.1371\/journal.pone.0003872","article-title":"The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes","volume":"3","author":"Polymenidou","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.str.2013.11.009_bib47","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM200105173442006","article-title":"Shattuck lecture\u2014neurodegenerative diseases and prions","volume":"344","author":"Prusiner","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.str.2013.11.009_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1750-3639.1995.tb00575.x","article-title":"The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system","volume":"5","author":"Richardson","year":"1995","journal-title":"Brain Pathol."},{"key":"10.1016\/j.str.2013.11.009_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/bj3420207","article-title":"Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126","volume":"342","author":"Salmona","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.str.2013.11.009_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/wcms.1121","article-title":"An overview of the Amber biomolecular simulation package","volume":"3","author":"Salomon-Ferrer","year":"2013","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.str.2013.11.009_bib51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature05695","article-title":"Atomic structures of amyloid cross-beta spines reveal varied steric zippers","volume":"447","author":"Sawaya","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.str.2013.11.009_bib52","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1006\/bbrc.1993.1977","article-title":"Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein","volume":"194","author":"Selvaggini","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.str.2013.11.009_bib53","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1073\/pnas.0810680105","article-title":"De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis","volume":"106","author":"Sigurdson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2013.11.009_bib54","doi-asserted-by":"crossref","first-page":"13840","DOI":"10.1523\/JNEUROSCI.3504-11.2011","article-title":"Spongiform encephalopathy in transgenic mice expressing a point mutation in the \u03b22-\u03b12 loop of the prion protein","volume":"31","author":"Sigurdson","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.str.2013.11.009_bib55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/bmb\/66.1.87","article-title":"Prion propagation in cultured cells","volume":"66","author":"Solassol","year":"2003","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.str.2013.11.009_bib56","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jmb.2010.09.060","article-title":"Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding","volume":"404","author":"van der Kamp","year":"2010","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.str.2013.11.009_bib57","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.1103932","article-title":"Human prion protein with valine 129 prevents expression of variant CJD phenotype","volume":"306","author":"Wadsworth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.str.2013.11.009_bib58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.str.2008.12.018","article-title":"Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein","volume":"17","author":"Walsh","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.str.2013.11.009_bib59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.str.2013.11.009_bib60","first-page":"311","article-title":"Prion related disorders","volume":"33","author":"Will","year":"1999","journal-title":"J.\u00a0R. Coll. Physicians Lond."},{"key":"10.1016\/j.str.2013.11.009_bib61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2013.11.009_bib62","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1046-5928(03)00195-5","article-title":"On-column purification and refolding of recombinant bovine prion protein: using its octarepeat sequences as a natural affinity tag","volume":"32","author":"Yin","year":"2003","journal-title":"Protein Expr. Purif."}],"container-title":["Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212613004590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212613004590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T11:55:51Z","timestamp":1647863751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969212613004590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0969212613004590"],"URL":"https:\/\/doi.org\/10.1016\/j.str.2013.11.009","relation":{},"ISSN":["0969-2126"],"issn-type":[{"value":"0969-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural Basis of Prion Inhibition by Phenothiazine Compounds","name":"articletitle","label":"Article Title"},{"value":"Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.str.2013.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}